chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Blister, Nasopharyngitis, Pain
Clinical narrative: All of a sudden I have had blisters, to have little blisters bumps like I have had about 3 or 4 blisters bumps on me; Cold; No taste; No smell; Coughing up phlegm; Pain; This is a spontaneous report from a contactable consumer (patient).   A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via intramuscular, administered in right arm on 29Mar2021 (at the age of 59-years) as dose 1, single for covid-19 immunization. Patient relevant medical history includes diabetic, congestive heart failure, blood pressure high and cholesterol. The patient concomitant medications includes metformin (dosage text: 500 mg, two times a day, tablet, orally, indication: diabetic), atorvastatin (dosage text: 40 mg, one tablet by mouth, one time a day, indication: cholesterol), metoprolol (dosage text: 100 mg, tablet, one time a day, orally, indication: congestive heart failure), benazepril (dosage text: 10 mg, one tablet by mouth, indication: blood pressure high) and hydrochlorothiazide (dosage text: 25 mg by mouth, one time a day, it was pill and for heart). The patient was calling and had this COVID Shot. The patient had the Pfizer Shot on the 29Mar and had 'real' (not clear) side effects with it. This was the first shot the patient had, first shot the patient had it caused her to had pain, and then all of a sudden had blisters, to had little blisters bumps like the patient had about 3 or 4 blisters bumps on her and had a cold. And now the patient had no taste, no smell and no taste. It started the day after shot, 29Mar2021. The pain started experiencing the same day, when the patient left the facility 29Mar2021. The cold had went away, the patient just did not miss this you know coughing up phlegm. Lot number: The patient think it was EL2 or something and back numbers are 8733. The patient did not know if this was a L or 1 or 2. So, they had got a bunch of stuff together and it was hard to tell if it was F2, because it looks like L2 or maybe it could be E12. The only numbers that the patient saw on this card was what the patient just gave them and had got Pfizer 1 dose. The patient did not had any treatment for adverse event. The outcome of the events was unknown except the outcome of event pain and anosmia was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough
Clinical narrative: All of a sudden I have had blisters, to have little blisters bumps like I have had about 3 or 4 blisters bumps on me; Cold; No taste; No smell; Coughing up phlegm; Pain; This is a spontaneous report from a contactable consumer (patient).   A 59-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: unknown), via intramuscular, administered in right arm on 29Mar2021 (at the age of 59-years) as dose 1, single for covid-19 immunization. Patient relevant medical history includes diabetic, congestive heart failure, blood pressure high and cholesterol. The patient concomitant medications includes metformin (dosage text: 500 mg, two times a day, tablet, orally, indication: diabetic), atorvastatin (dosage text: 40 mg, one tablet by mouth, one time a day, indication: cholesterol), metoprolol (dosage text: 100 mg, tablet, one time a day, orally, indication: congestive heart failure), benazepril (dosage text: 10 mg, one tablet by mouth, indication: blood pressure high) and hydrochlorothiazide (dosage text: 25 mg by mouth, one time a day, it was pill and for heart). The patient was calling and had this COVID Shot. The patient had the Pfizer Shot on the 29Mar and had 'real' (not clear) side effects with it. This was the first shot the patient had, first shot the patient had it caused her to had pain, and then all of a sudden had blisters, to had little blisters bumps like the patient had about 3 or 4 blisters bumps on her and had a cold. And now the patient had no taste, no smell and no taste. It started the day after shot, 29Mar2021. The pain started experiencing the same day, when the patient left the facility 29Mar2021. The cold had went away, the patient just did not miss this you know coughing up phlegm. Lot number: The patient think it was EL2 or something and back numbers are 8733. The patient did not know if this was a L or 1 or 2. So, they had got a bunch of stuff together and it was hard to tell if it was F2, because it looks like L2 or maybe it could be E12. The only numbers that the patient saw on this card was what the patient just gave them and had got Pfizer 1 dose. The patient did not had any treatment for adverse event. The outcome of the events was unknown except the outcome of event pain and anosmia was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 70.0
Sex: U
Vaccine: COVID19
Symptoms: Cough, Feeling abnormal, Myalgia, Night sweats
Clinical narrative: massive cough and only lasted a couple hour and then it went away; Felt bad for couple of days; Night sweat; funny sensation like the sore muscle down the fronts of leg and then across abdomen; This is a spontaneous report from contactable consumer (patient) reporting for self. A 70-year-old patient of an unspecified gender received BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6206; Expiration Date: 30Jun2021) via an unspecified route of administration, administered in Arm Left on 18Mar2021 (at the age of 70 year) as dose 2, single for covid-19 immunization. The patient medical history was not reported. There were no concomitant medications. Historical vaccine included BNT162B2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6198; Expiration Date: 30Jun2021) via an unspecified route of administration, administered in arm left on 25Feb2021 as dose 1, single (at the age of 70) for covid-19 immunization. The patient experienced a massive cough and only lasted a couple hour and then it went away, felt bad for couple of days both on 03Apr2021, night sweat on 21Mar2021, funny sensation like the sore muscle down the fronts of leg and then across abdomen on an unspecified date in 2021. Patient was received no treatment for the events. Patient reported that an unusual reaction at day 16 after the second vaccine develop a massive cough and only lasted a couple hour and then it went away and not had any problem since then however it was a very massive cough, that just appear after nowhere patient woke up at 1:30 in the morning woke up with the catch in throat and when went to clear throat had a cough that would not stop and could not control it, it was lasted, little episode back 20 min each and lasted about couple of hour and then little bit later, was just fine. Patient had the night sweat on the third night, big cough and it wouldn't quit and couldn't catch breath, just couldn't hardly make it stop, well it didn't last very long it within an hour had gotten over the cough and fit actually went back to sleep, woke up the next morning, tried to make that cough come again and it wouldn't there, Patient don't know any other reason other than the vaccine that could have done that, also reported as 2 days ago like day 18 after vaccination of second vaccination was exposed to live Covid in face, a man cough in face and he was very ill so with the Covid so had a really strong exposure just like 2 days ago and don't know they might want to contact and see if patient contract that disease or maybe the vaccination will keep from getting it. The outcome of the event massive cough and only lasted a couple hour and then it went away was recovered on an unknown date in 2021; outcome of other events was unknown.  Investigation Assessment: No  No follow-up attempts are possible. No further information is expected.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Arthritis, Joint noise, Magnetic resonance imaging, X-ray
Clinical narrative: Right knee has normally level 2 pain from arthritis and possible torn maniscus. 24 hours after 2nd shot extreme pain in knee, turning over in bed, walking, putting on shoe, getting into shower extreme; knee would snap; This is a spontaneous report from a contactable consumer(patient). This 55-year-old male consumer reported for himself. A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: ER8732), dose 2 via an unspecified route of administration, administered in Arm Left on 05Apr2021 13:00 (at the age of 55-years-old) as a single dose for covid-19 immunization. Medical history included skin cancer, dermatitis contact. Concomitant medication(s) in two weeks included beclometasone dipropionate, chloramphenicol, clotrimazole (CBC); ibuprofen (ADVIL [IBUPROFEN]); paracetamol (TYLENOL). Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number: En6208), dose 1 via an unspecified route of administration, administered in Arm Left on 15Mar2021 13:00 (at the age of 55-years-old) as a single dose for covid-19 immunization. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient had allergies with Mastisol, adhesive on steri strips. On 06Apr2021 11:00, the patient experienced right knee has normally level 2 pain from arthritis and possible torn maniscus. 24 hours after 2nd shot extreme pain in knee, turning over in bed, walking, putting on shoe, getting into shower extremely painful, 7 on scale, leading up to this knee would snap while letting off of gas pedal while driving (loud electrical arch type snap). Received cortisone shot for relief. No known reason for sudden amplification of symptoms. The patient underwent lab tests and procedures which included magnetic resonance imaging: unknown on Apr2021, x-ray: unknown on Apr2021. The adverse event resulted in emergency room/department or urgent care visit. The patient received treatment with cortisone shot to knee, X-ray and mri. Outcome of the event was recovered, at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Cough, Dizziness, Fatigue, Feeling abnormal
Clinical narrative: armpit is still swollen and sore; Tiredness; Light cough; Serious migraine; Nausea; Armpits to swell up really bad; Whole body muscle soreness on day 2; Second shot caused me to become loopy and lightheaded on day 1, 2, and 3; Second shot caused me to become loopy and lightheaded on day 1, 2, and 3; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 07Apr2021 at 16:15 (at the age of 36-year-old) as a single dose for COVID-19 immunization. Medical history included ongoing asthma. The patient previously took amoxicillin and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 16:15 (at the age of 36-year-old) as a single dose for COVID-19 immunization. The first shot caused muscle soreness on day 1 and 2 and tiredness day 1, 2, and 3. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 16:45, the patient become loopy and lightheaded on day 1, 2, and 3. On 08Apr2021 on day 2, had whole body muscle soreness and armpits to swell up really bad. Patient was on day 5 after it and left armpit is still swollen and sore. On 09Apr2021 on day 3, had a serious migraine and nausea. On 10Apr2021 on day 4, the patient started having a light cough and still persists on day 5. On 10Apr2021 on day 4, tiredness and lightheadedness. Patient was on day 5 after it and left armpit is still swollen and sore on 11Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events loopy, lightheaded, migraine, muscle soreness, nausea and tiredness was recovering at the time of this report. The clinical outcome of the events armpits to swell up really bad, armpit is still swollen and sore and cough was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Nausea, Swelling
Clinical narrative: armpit is still swollen and sore; Tiredness; Light cough; Serious migraine; Nausea; Armpits to swell up really bad; Whole body muscle soreness on day 2; Second shot caused me to become loopy and lightheaded on day 1, 2, and 3; Second shot caused me to become loopy and lightheaded on day 1, 2, and 3; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration on 07Apr2021 at 16:15 (at the age of 36-year-old) as a single dose for COVID-19 immunization. Medical history included ongoing asthma. The patient previously took amoxicillin and experienced allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 17Mar2021 at 16:15 (at the age of 36-year-old) as a single dose for COVID-19 immunization. The first shot caused muscle soreness on day 1 and 2 and tiredness day 1, 2, and 3. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 at 16:45, the patient become loopy and lightheaded on day 1, 2, and 3. On 08Apr2021 on day 2, had whole body muscle soreness and armpits to swell up really bad. Patient was on day 5 after it and left armpit is still swollen and sore. On 09Apr2021 on day 3, had a serious migraine and nausea. On 10Apr2021 on day 4, the patient started having a light cough and still persists on day 5. On 10Apr2021 on day 4, tiredness and lightheadedness. Patient was on day 5 after it and left armpit is still swollen and sore on 11Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events loopy, lightheaded, migraine, muscle soreness, nausea and tiredness was recovering at the time of this report. The clinical outcome of the events armpits to swell up really bad, armpit is still swollen and sore and cough was not resolved at the time of this report.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: got the 2nd shot- am still having itching issues; This is a spontaneous report from a contactable consumer (Patient).   A female patient of unknown age (reported as age: 80; unit: unknown) received second dose of BNT162B2 (PFIZER-BIONTECH m-RNA COVID-19 VACCINE, formulation: Solution for injection, Lot number: EN6208 and expiry date was not reported), via an unspecified route of administration into left arm on 25Mar2021 as dose 2, single as COVID-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included: known allergies to sulfa, penicillin and Macrobid. Concomitant medications were not reported. The patient did not receive any vaccine in four weeks of Covid-19 shot. The patient received other unspecified medications in two weeks of Covid-19 shot. The patient was neither diagnosed with covid prior vaccination nor tested for covid post vaccination. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EM9809) via an unspecified route of administration into left arm on 25Feb2021 at 01:45 PM as dose 1, single for Covid-19 immunization. 5 days after 1st dose started to itch on torso on 02Mar2021 and started to abate till got the 2nd shot and was still having itching issues since an unspecified date. The patient was treated with topical creams and outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Gingival swelling, Sinus disorder, Swelling face, Toothache
Clinical narrative: left side of my face swelled (mostly in the sinus regions); tooth pain from upper gum swelling under his nose; tooth pain from upper gum swelling under his nose; just thought it was just a sinus issue; This is a spontaneous report from a contactable consumer (patient). A 50-year-old male patient reported for himself that he received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6205), via an unspecified route, administered in arm left on 20Mar2021 at 14:45 (age at vaccination was 50-year-old) as dose 1, single for covid-19 immunization at public health clinic. No other vaccines were received in four weeks. Medical history included minor asthma and high blood pressure; both from an unknown date and unknown if ongoing. No known allergies were reported. Concomitant medications included colecalciferol (VITAMIN D [COLECALCIFEROL]), ibuprofen (MOTRIN [IBUPROFEN]), diphenhydramine (DIPHENHYDRAMINE), paracetamol, pseudoephedrine hydrochloride (TYLENOL SINUS [PARACETAMOL; PSEUDOEPHEDRINE HYDROCHLORIDE]); all taken in two weeks for an unspecified indication, start and stop date were not reported. Report stated that, on 21Mar2021 at 13:00, a day or two after the injection the patient's left side of face swelled (mostly in the sinus regions) and tooth pain from upper gum swelling under his nose so the patient just thought it was just a sinus issue so he took unspecified over the counter meds and didn't think anything of it. No treatment was received for the adverse events. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was not tested for COVID-19. Outcome of the events was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dizziness, SARS-CoV-2 test, Throat irritation, Urticaria
Clinical narrative: Lightheaded; Anxious; Wheals on neck; Scratchy throat; This is a spontaneous report from a contactable nurse, other health care professional. A 22-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), dose 1 intramuscular, administered in right arm on 14Apr2021 13:30 (at the age of 22-years-old) (Lot Number: EW0153) as dose 1, single for covid-19 immunization at school or student health clinic facility. Medical history included anxiety, depression and polycystic ovaries (Pcos) all were started from an unknown date and unknown if ongoing. Patient had known allergies to bees, patient previously took doxycycline and experienced drug allergy. Patient received other medications within two weeks of vaccination was taken as concomitant medications which included testosterone taken for an unspecified indication, start and stop date were not reported. On 14Apr2021 13:45, patient experienced lightheaded, anxious, wheals on neck, scratchy throat and patient walked to tent. These events resulted in emergency room/department or urgent care visit via ambulance and all events were considered as medically significant due to treatment with Epinephrine, Oxygen inhalation to prevent a serious outcome. Patient was pregnant at the time of vaccination was reported as unknown. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received any other vaccines within four weeks prior to the vaccination was reported as unknown. Therapeutic measures included epinephrine 1:1000 0.5ml left thigh; oxygen 10 L via mask; diphenhydraimine 50mg IM Left deltoid, IV started were taken as a result of all events. The patient underwent lab tests and procedures which included nasal swab type, COVID-19 virus test post vaccination on 08Sep2020; on 25Jan2021 and on 05Feb2021 with negative results. The outcome of the events was recovered on 14Apr2021 at 13:45.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: As there is limited information in the case provided, the causal association between the events and the suspect drug BNT162B2 cannot be excluded.  The impact of this report on the benefit-risk profile of the Pfizer product and on the conduct of the study is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary mass, Body temperature, Chills, Diarrhoea
Clinical narrative: Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen); vomiting; nausea; diarrhea; sore throat; chills; muscle and joint aches; muscle and joint aches; rashes; rashes and lumps underneath both armpits; ear pain; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 24-years old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 13Apr2021 14:45 (at the age of 24-years old) as dose 2, single for covid-19 immunisation. Medical history included angioedema, bouts of anaphylaxis, rashes, Penicillin allergy and Septra allergy. Concomitant medication included ethinylestradiol, norelgestromin (XULANE). Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 22Mar2021 14:15(at the age of 24-years old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having covid prior vaccination and has unknown if covid tested post vaccination. On 14Apr2021 patient experienced Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen), nausea, vomiting, diarrhea, chills, muscle and joint aches, rashes and lumps underneath both armpits, ear pain, sore throat. I am suffering bruh. Patient underwent lab test and procedure included Body temperature 102.00 Fahrenheit. It was unknown if patient has taken treatment for events.  The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Myalgia, Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen); vomiting; nausea; diarrhea; sore throat; chills; muscle and joint aches; muscle and joint aches; rashes; rashes and lumps underneath both armpits; ear pain; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 24-years old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 13Apr2021 14:45 (at the age of 24-years old) as dose 2, single for covid-19 immunisation. Medical history included angioedema, bouts of anaphylaxis, rashes, Penicillin allergy and Septra allergy. Concomitant medication included ethinylestradiol, norelgestromin (XULANE). Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 22Mar2021 14:15(at the age of 24-years old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having covid prior vaccination and has unknown if covid tested post vaccination. On 14Apr2021 patient experienced Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen), nausea, vomiting, diarrhea, chills, muscle and joint aches, rashes and lumps underneath both armpits, ear pain, sore throat. I am suffering bruh. Patient underwent lab test and procedure included Body temperature 102.00 Fahrenheit. It was unknown if patient has taken treatment for events.  The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vomiting
Clinical narrative: Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen); vomiting; nausea; diarrhea; sore throat; chills; muscle and joint aches; muscle and joint aches; rashes; rashes and lumps underneath both armpits; ear pain; This is a spontaneous report from a contactable consumer or other non hcp(patient). A 24-years old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 13Apr2021 14:45 (at the age of 24-years old) as dose 2, single for covid-19 immunisation. Medical history included angioedema, bouts of anaphylaxis, rashes, Penicillin allergy and Septra allergy. Concomitant medication included ethinylestradiol, norelgestromin (XULANE). Patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: not reported) via an unspecified route of administration, administered in Arm Left on 22Mar2021 14:15(at the age of 24-years old) as dose 1, single for covid-19 immunisation. The patient was not pregnant at time of vaccination. The patient was not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not having covid prior vaccination and has unknown if covid tested post vaccination. On 14Apr2021 patient experienced Fever (102.00) that doesnt subside much with medication (going between 500-800 mg ibuprofen, 500mg of acetaminophen), nausea, vomiting, diarrhea, chills, muscle and joint aches, rashes and lumps underneath both armpits, ear pain, sore throat. I am suffering bruh. Patient underwent lab test and procedure included Body temperature 102.00 Fahrenheit. It was unknown if patient has taken treatment for events.  The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Pruritus
Clinical narrative: Loss of appetite/experiencing the same symptoms; both had itching in both feet 1st week; This is a spontaneous report from a contactable consumer or other non-HCP (parent reported for daughter). A female patient of an unspecified age received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- ER8737) via an unspecified route of administration in left arm on 01Apr2021 14:45 in left arm as dose 1, single for COVID-19 immunization. Vaccination facility type was reported as Pharmacy/drug store. Medical history included mental illness (reported as mentally ill). The concomitant medications were not reported. The patient had not taken other vaccines within 4 weeks. The patient did not have COVID-19, prior to vaccination and was not tested for COVID-19, post vaccination. On an unspecified date in Apr2021, the patient experienced loss of appetite and had itching in both feet first week. Patient was mentally ill and was experiencing the same symptoms but decreasing for her. No nose bleed for daughter. The clinical outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: sore shoulder; This is a spontaneous report from a contactable consumer (patient). A 60-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection) via an unspecified route of administration, administered in arm left on Mar2021 (Lot number: ER8727, age at vaccination 60-year-old) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. There were no known allergies. Facility type vaccine was other. There was no other vaccine in four weeks. There was no COVID prior vaccination. There was no COVID tested post vaccination. On an unknown date in Mar2021 at 03:00 PM, the patient experienced sore shoulder for 24 hours. There was no treatment received for adverse event. It was reported that no other vaccine in four weeks, no COVID prior vaccination, no COVID tested post vaccination and no known allergies. The outcome of event was reported as recovered.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Body temperature, Chills, Decreased appetite, Lymphadenopathy
Clinical narrative: 104.7 fever; chills; pain throughout body; swollen lymph node under right arm; not hungry; pain in lower back; This is spontaneous report from a contactable consumer (Patient).  A 39-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EW0158) via an unspecified route of administration in arm right on 12Apr2021 08:00 (age at the time of the vaccination 39 year) as dose 2, single for COVID-19 immunization. Medical history included sleep apnoea, hashimotos and known allergies: Penicillin. Concomitant medications included levothyroxine sodium (SYNTHROID). Patient previously received first dose of bnt162b2 (Lot Number: ER8733) via an unspecified route of administration in arm right on 23Mar2021 08:00 (age at the time of the vaccination 39 year) as dose 1, single for COVID-19 immunization. Facility type vaccine was at hospital. No other vaccine in four weeks. No COVID prior vaccination. Not tested COVID post vaccination. On 12Apr2021 12:00, the patient experienced 104.7 fever, chills, pain throughout body, swollen lymph node under right arm, not hungry, pain in lower back. On 12Apr2021, the patient underwent lab tests and procedures which included fever: 104.7. No treatment given. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: 104.7 fever; chills; pain throughout body; swollen lymph node under right arm; not hungry; pain in lower back; This is spontaneous report from a contactable consumer (Patient).  A 39-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection, Lot Number: EW0158) via an unspecified route of administration in arm right on 12Apr2021 08:00 (age at the time of the vaccination 39 year) as dose 2, single for COVID-19 immunization. Medical history included sleep apnoea, hashimotos and known allergies: Penicillin. Concomitant medications included levothyroxine sodium (SYNTHROID). Patient previously received first dose of bnt162b2 (Lot Number: ER8733) via an unspecified route of administration in arm right on 23Mar2021 08:00 (age at the time of the vaccination 39 year) as dose 1, single for COVID-19 immunization. Facility type vaccine was at hospital. No other vaccine in four weeks. No COVID prior vaccination. Not tested COVID post vaccination. On 12Apr2021 12:00, the patient experienced 104.7 fever, chills, pain throughout body, swollen lymph node under right arm, not hungry, pain in lower back. On 12Apr2021, the patient underwent lab tests and procedures which included fever: 104.7. No treatment given. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Blood follicle stimulating hormone, Blood follicle stimulating hormone increased, Heavy menstrual bleeding, Polymenorrhoea, SARS-CoV-2 test
Clinical narrative: My FSH levels were taken on 12/7/2021 (one week after dose one) and were 9.1 (high end of normal prompting retest in three cycles).; My period which previously was 27 days consistently and light flow. Since December my period has been very heavy and also my cycle has been 23-25 days in length.; My period which previously was 27 days consistently and light flow. Since December my period has been very heavy and also my cycle has been 23-25 days in length.; This is a spontaneous report from a contactable other hcp (patient). This is the first of two reports. A 38-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: ELI284) dose 1 via an unspecified route of administration, administered in Arm Right on 30Dec2020 07:00 as DOSE 1, SINGLE for covid-19 immunisation (at the age 38 years). The patient was not pregnant at the time of vaccination. Medical history included drug hypersensitivity with penicillin (Known allergies: Penicillin) and chronic fatigue syndrome from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (ADVIL [IBUPROFEN]). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Since the vaccination, the patient had been tested for COVID-19. The patient experienced my fsh levels were taken on 12/7/2021 (one week after dose one) and were 9.1 (high end of normal prompting retest in three cycles) on 07Jan2021, my period which previously was 27 days consistently and light flow. Since december my period has been very heavy and also my cycle has been 23-25 days in length on Dec2020. Therapeutic measures were taken as a result of all the events included treatment with patient was not being treated by a fertility doctor. The event resulted in doctor or other healthcare professional office/clinic visit. The patient underwent lab tests and procedures which included blood follicle stimulating hormone: 9.1 (high end of normal prompting retest in three cycles) on 07Jan2021 9.1, sars-cov-2 test: negative on 17Dec2020 test type: Nasal swab. Binax Now as well as by PCR. I have had daily & weekly testing since December for work, sars-cov-2 test: negative on 17Dec2020 Nasal swab Binax Now as well as by PCR test. The clinical outcome of all the events were unknown.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: reaction; This is a spontaneous report from a contactable consumer or other non healthcare professional (patient) from a Pfizer sponsored program. A 57-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation : solution for injection, Batch/Lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date (at the age of 57-years old) as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.On an unspecified date, the patient experienced reaction and was taken to the emergency room. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Illness, Rhinorrhoea
Clinical narrative: Runny nose; Constant cough; Barely can breathe; I have really been sick; This is a spontaneous case received from a contactable Consumer (patient). A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number was not reported, Expiry Date: Unknown), via an unspecified route of administration, administered on an unspecified date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced constant cough, runny nose, barely can breathe and the patient has really been sick. Reporter stated, "I had my Covid shot like on last Thursday and ever since Sunday I have really been sick. Like constant cough, runny nose, barely can breathe. Should I go into the emergency room?" The outcome of all the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Pruritus, Sensitive skin
Clinical narrative: This is a spontaneous report from a contactable consumer or other non-HCP (patient wife). A male patient, of an unspecified age, received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, solution for injection, batch/lot# not reported), via an unspecified route of administration, on an unspecified date (reported as in last week), single dose, for COVID-19 immunization. Patient medical history included he has an allergy. The concomitant medications not reported. The patient experienced sensitive skin. The allergy season is just starting, and his skin became itchy after getting the vaccine. He had allergies on an unspecified date. Reporter asked is it ok to take Benadryl for sensitive skin. Reporter clarified he had this allergy before the vaccine, but not this year because the allergy season is just starting. His itchy skin started after getting the vaccine. No treatment received for the event. The outcome of the event: unknown. No follow-up attempts possible. Information about batch/lot number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Feeling cold, Headache, Myalgia
Clinical narrative: both sides of neck muscles achy radiated down both arms; nausea's (vomited only 1x); nausea's (vomited only 1x),; rash across the top upper part of back; at 8:00pm got chills extremely bad had a hard time getting warm,1:00am finally got warm; at 8:00pm got chills extremely bad had a hard time getting warm,1:00am finally got warm; dizzy again like 1st time; major headache; This is a spontaneous report from a contactable consumer (patient) reported herself. A 62-year-old non pregnant female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0158) via an unspecified route, administered in left arm on 09Apr2021 at 13:30 (age at vaccination 62 years) as dose 2, single for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included chronic neck pain due to auto accident in 1997 and had allergies to penicillin. She received other medications within 2 weeks of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER2613) via an unspecified route, administered in left arm on 19Mar2021 at 13:30 (age at vaccination 62 years) as dose 1, single for COVID-19 immunization and experienced dizzy after 5 min of injection. On 09Apr2021 16:00, patient experienced dizzy again like 1st time, major headache, at 20:00 got chills extremely bad had a hard time getting warm, at 1:00 finally got warm. Next day both sides of neck muscles achy radiated down both arms, very nausea's (vomited only 1x). Then chills started again at 17:00 lasted till midnight. And lastly she developed a rash across the top upper part of back. Seriousness of the events was reported as non-serious. Prior vaccination she was not diagnosed with COVID-19 and since the vaccination she has not been tested for COVID-19. Adverse events did not result in physician office visit or emergency room visit. No treatment for the adverse events. The outcome of all events was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash, Vomiting
Clinical narrative: both sides of neck muscles achy radiated down both arms; nausea's (vomited only 1x); nausea's (vomited only 1x),; rash across the top upper part of back; at 8:00pm got chills extremely bad had a hard time getting warm,1:00am finally got warm; at 8:00pm got chills extremely bad had a hard time getting warm,1:00am finally got warm; dizzy again like 1st time; major headache; This is a spontaneous report from a contactable consumer (patient) reported herself. A 62-year-old non pregnant female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0158) via an unspecified route, administered in left arm on 09Apr2021 at 13:30 (age at vaccination 62 years) as dose 2, single for COVID-19 immunization at hospital. The patient was not pregnant at the time of vaccination. The patient's medical history included chronic neck pain due to auto accident in 1997 and had allergies to penicillin. She received other medications within 2 weeks of vaccination. She did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: ER2613) via an unspecified route, administered in left arm on 19Mar2021 at 13:30 (age at vaccination 62 years) as dose 1, single for COVID-19 immunization and experienced dizzy after 5 min of injection. On 09Apr2021 16:00, patient experienced dizzy again like 1st time, major headache, at 20:00 got chills extremely bad had a hard time getting warm, at 1:00 finally got warm. Next day both sides of neck muscles achy radiated down both arms, very nausea's (vomited only 1x). Then chills started again at 17:00 lasted till midnight. And lastly she developed a rash across the top upper part of back. Seriousness of the events was reported as non-serious. Prior vaccination she was not diagnosed with COVID-19 and since the vaccination she has not been tested for COVID-19. Adverse events did not result in physician office visit or emergency room visit. No treatment for the adverse events. The outcome of all events was recovered on an unknown date in Apr2021. No follow-up attempts are needed. No further information is expected.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature increased, Diarrhoea, Exposure to SARS-CoV-2, Nasal congestion
Clinical narrative: for 2 weeks had congestion and 99.1 temperature; really bad diarrhea and vomiting; really bad diarrhea and vomiting; . She has now been exposed to someone that had Covid; for 2 weeks had congestion and 99.1 temperature; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported, expiry date: unknown) as dose 1, single (age at vaccination:80-Years-old) for COVID-19 immunisation. The patient medical history was not reported and none concomitant medications were reported. It was reported that patient received the Pfizer vaccine back on 20Mar and she talked to somebody that had a horrible accent and was hard to understand. They didn't answer her question, just asked a lot of questions. On that day of her vaccine, she ended up getting really bad diarrhea and vomiting. She is 80 years old and is concerned about the second dose. She has now been exposed to someone that had Covid and she has for 2 weeks had congestion and 99.1 temperature. Should she get the second dose that is schedule for this Saturday which was scheduled at 4 weeks. On an unspecific date the patient underwent lab tests and procedures which included body temperature: 99.1. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: for 2 weeks had congestion and 99.1 temperature; really bad diarrhea and vomiting; really bad diarrhea and vomiting; . She has now been exposed to someone that had Covid; for 2 weeks had congestion and 99.1 temperature; This is a spontaneous report from a non-contactable consumer or other non hcp.  A 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection via an unspecified route of administration on 20Mar2021 (Batch/Lot number was not reported, expiry date: unknown) as dose 1, single (age at vaccination:80-Years-old) for COVID-19 immunisation. The patient medical history was not reported and none concomitant medications were reported. It was reported that patient received the Pfizer vaccine back on 20Mar and she talked to somebody that had a horrible accent and was hard to understand. They didn't answer her question, just asked a lot of questions. On that day of her vaccine, she ended up getting really bad diarrhea and vomiting. She is 80 years old and is concerned about the second dose. She has now been exposed to someone that had Covid and she has for 2 weeks had congestion and 99.1 temperature. Should she get the second dose that is schedule for this Saturday which was scheduled at 4 weeks. On an unspecific date the patient underwent lab tests and procedures which included body temperature: 99.1. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.